FOUNDER PROFILE

Gabriel de Maetzu

Gabriel de Maetzu

Gabriel de Maetzu

Gabriel de Maeztu is CTO and co-founder of IOMED Medical Solutions, which facilitates data extraction from electronic health records (EHR) and where he has worked since 2016. He had the idea for the software in 2014 and worked on it from then, completing two internships during that time: at QMENTA, formerly Mint Labs, a US drug development startup dedicated to brain diseases (where he worked in data science) and at Barcelona bioresearch center IDIBAPS in neuro-imaging research.

De Maeztu holds a doctorate in Medicine from the International University of Catalonia, where he first had the idea for IOMED. He also holds a bachelor’s in Mathematics and a postgraduate qualification in Data Processing, Data Science and Big Data. He was also previously a developer at Barcelona tech agency Chroma Branding. 

Limited Reading

The rest of the content is only available if you are logged in.

Limited Reading

RELATED INSIGHTS

Gift This Article

The gift link can be opened by one recipient only.

You have 19 gift credits left this month

Your payment was not successful.

Please make sure you have entered your payment details correctly. Or try again in a few moments.

small logo

The discount code you entered is invalid

Please make sure you have entered your discount code correctly. Or try again in a few moments.

Download successful.

Your sample has been sent. Please check your email.

By accessing and using www.compasslist.com and all pages within the domain (the “Website”), You accept and agree to have read, understood, accepted and agreed to be bound by the Terms of Use and Privacy Policy in full. If you disagree with all or any part of these Terms of Use and Privacy Policy, please do not use or continue any further use of this website. You acknowledge that you are aware that this Website contains an archive of existing content as at 31 December 2021 and is not being actively managed. We are under no obligation to update the content on this Website and, accordingly, no new content or articles will be posted to the Website after 31 December 2021.